TY - JOUR AU - Hebert P. AU - Finfer Simon AU - Dodek P. AU - Bellomo R. AU - Heyland D. AU - Chittock D. AU - Dhingra V. AU - Foster D. AU - Henderson W. AU - Cook D. AU - McArthur C. AU - Higgins A. AU - Robinson B. AU - Ronco J. AU - Mitchell I. AU - Li Y. AU - Myburgh J AB -

PURPOSE: To compare the effect of intensive versus conventional blood glucose control in patients with traumatic brain injury. METHODS: In a large international randomized trial patients were randomly assigned to a target blood glucose (BG) range of either 4.5-6.0 mmol/L (intensive control) or <10 mmol/L (conventional control). Patients with traumatic brain injury (TBI) were identified at randomization and data were collected to examine the extended Glasgow outcome score (includes mortality) at 24 months. RESULTS: Of the 6104 randomized patients, 391 satisfied diagnostic criteria for TBI; 203 (51.9%) were assigned to intensive and 188 (48.1%) to conventional control; the primary outcome was available for 166 (81.8%) and 149 (79.3%) patients, respectively. The two groups had similar baseline characteristics. At 2 years 98 (58.7%) patients in the intensive group and 79 (53.0%) in the conventional group had a favorable neurological outcome (odds ratio [OR] 1.26, 95% CI 0.81-1.97; P = 0.3); 35 patients (20.9%) in the intensive group and 34 (22.8%) in the conventional group had died (OR 0.90, 95% CI 0.53-1.53; P = 0.7); moderate hypoglycemia (BG 2.3-3.9 mmol/L; 41-70 mg/dL) occurred in 160/202 (79.2%) and 17/188 (9.0%), respectively (OR 38.3, 95% CI 21.0-70.1; P < 0.0001); severe hypoglycemia (BG

AN - 26088909 BT - Intensive Care Medicine DP - NLM ET - 2015/06/20 LA - eng LB - AUS
CCT
FY16 M1 - 6 N1 - NICE-SUGAR Study Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group and the Canadian Critical Care Trials Group
Finfer, Simon
Chittock, Dean
Li, Yang
Foster, Denise
Dhingra, Vinay
Bellomo, Rinaldo
Cook, Deborah
Dodek, Peter
Hebert, Paul
Henderson, William
Heyland, Daren
Higgins, Alisa
McArthur, Colin
Mitchell, Imogen
Myburgh, John
Robinson, Bruce
Ronco, Juan
United States
Intensive Care Med. 2015 Jun;41(6):1037-47. doi: 10.1007/s00134-015-3757-6. Epub 2015 Jun 19. N2 -

PURPOSE: To compare the effect of intensive versus conventional blood glucose control in patients with traumatic brain injury. METHODS: In a large international randomized trial patients were randomly assigned to a target blood glucose (BG) range of either 4.5-6.0 mmol/L (intensive control) or <10 mmol/L (conventional control). Patients with traumatic brain injury (TBI) were identified at randomization and data were collected to examine the extended Glasgow outcome score (includes mortality) at 24 months. RESULTS: Of the 6104 randomized patients, 391 satisfied diagnostic criteria for TBI; 203 (51.9%) were assigned to intensive and 188 (48.1%) to conventional control; the primary outcome was available for 166 (81.8%) and 149 (79.3%) patients, respectively. The two groups had similar baseline characteristics. At 2 years 98 (58.7%) patients in the intensive group and 79 (53.0%) in the conventional group had a favorable neurological outcome (odds ratio [OR] 1.26, 95% CI 0.81-1.97; P = 0.3); 35 patients (20.9%) in the intensive group and 34 (22.8%) in the conventional group had died (OR 0.90, 95% CI 0.53-1.53; P = 0.7); moderate hypoglycemia (BG 2.3-3.9 mmol/L; 41-70 mg/dL) occurred in 160/202 (79.2%) and 17/188 (9.0%), respectively (OR 38.3, 95% CI 21.0-70.1; P < 0.0001); severe hypoglycemia (BG

PY - 2015 SN - 1432-1238 (Electronic)
0342-4642 (Linking) SP - 1037 EP - 47 T2 - Intensive Care Medicine TI - Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a subgroup of patients from the NICE-SUGAR study VL - 41 Y2 - FY16 ER -